Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $9.07 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.46.
Market Cap
9.07T
Revenue
4.67T
Profits
191.17B
PE Ratio
47.46
Profit Margin
4.10%
Dividend Yield
0.39%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | 1.26% | 1,589,333 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 613.99B | 0.73% | 3,866,413 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 471.27B | 0.35% | 4,500,621 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 350.19B | 1.72% | 8,066,171 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 337.78B | -0.60% | 4,790,072 | 450.53B |
| 6 | NVS | Novartis AG | 266.38B | -0.10% | 1,504,201 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 249.60B | 1.33% | 2,050,216 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 242.77B | -2.98% | 2,748,165 | 46.34B |
| 9 | AMGN | Amgen Inc. | 217.66B | -0.09% | 2,036,531 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 178.84B | -0.28% | 3,723,394 | 30.46B |
| 11 | ABT | Abbott Laboratories | 169.85B | -1.94% | 5,563,642 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 163.63B | -0.03% | 13,681,543 | 50.34B |
| 13 | PFE | Pfizer Inc. | 156.74B | 0.33% | 24,067,195 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.57B | -2.53% | 3,636,356 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 142.99B | -0.42% | 981,835 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 127.32B | -0.24% | 774,974 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.73B | 1.33% | 9,885,268 | 49.19B |
| 18 | MDT | Medtronic plc | 111.40B | -1.00% | 52,133,192 | 37.54B |
| 19 | CVS | CVS Health Corporation | 110.54B | -0.67% | 8,087,940 | 412.65B |
| 20 | MCK | McKesson Corporation | 107.46B | 0.68% | 680,430 | 410.98B |
| 21 | SYK | Stryker Corporation | 106.71B | -2.46% | 2,855,973 | 25.84B |
| 22 | SNY | Sanofi | 95.30B | 0.13% | 3,051,965 | 55.89B |
| 23 | GSK | GSK plc | 93.95B | 0.11% | 6,806,370 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 93.57B | -0.63% | 998,452 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.77B | 1.41% | 1,229,994 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 74.84B | -7.75% | 18,756,294 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 73.76B | 1.69% | 615,038 | 15.53B |
| 28 | CI | The Cigna Group | 72.50B | 1.14% | 1,093,334 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 61.14B | -0.50% | 10,299,187 | 21.00B |
| 30 | COR | Cencora, Inc. | 60.37B | 0.46% | 815,460 | 332.77B |
| 31 | ARGX | argenx SE | 58.81B | 1.93% | 430,053 | 5.32B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 58.70B | 1.63% | 3,097,362 | 28.42B |
| 33 | NTRA | Natera, Inc. | 57.75B | -5.87% | 2,499,196 | 2.71B |
| 34 | CAH | Cardinal Health, Inc. | 54.06B | 0.14% | 1,149,550 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 49.85B | -0.86% | 3,384,873 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 49.11B | -0.20% | 2,053,225 | 22.48B |
| 37 | HUM | Humana Inc. | 48.54B | 0.05% | 1,982,823 | 145.68B |
| 38 | A | Agilent Technologies, Inc. | 47.74B | -1.00% | 1,869,305 | 7.37B |
| 39 | MDLN | Medline Inc. | 46.74B | -0.70% | 8,878,452 | 29.94B |
| 40 | VEEV | Veeva Systems Inc. | 45.90B | 0.02% | 1,174,649 | 3.46B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 45.60B | -1.34% | 5,716,294 | 17.32B |
| 42 | WAT | Waters Corporation | 42.88B | -0.84% | 1,074,952 | 4.64B |
| 43 | RVMD | Revolution Medicines, Inc. | 42.84B | -3.76% | 1,631,562 | - |
| 44 | IQV | IQVIA Holdings Inc. | 42.79B | -2.30% | 1,105,040 | 16.98B |
| 45 | ILMN | Illumina, Inc. | 41.30B | -6.86% | 4,380,131 | 4.49B |
| 46 | ONC | BeOne Medicines AG | 41.25B | 0.31% | 319,914 | 6.13B |
| 47 | IDXX | IDEXX Laboratories, Inc. | 40.60B | -2.21% | 497,411 | 4.55B |
| 48 | HLN | Haleon plc | 39.30B | 0.57% | 12,837,561 | 14.80B |
| 49 | BIIB | Biogen Inc. | 32.93B | -0.31% | 1,008,075 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 32.45B | -0.39% | 2,434,093 | 2.54B |
| 51 | CNC | Centene Corporation | 31.92B | 0.48% | 3,661,698 | 180.30B |
| 52 | DXCM | DexCom, Inc. | 31.47B | -4.04% | 3,574,563 | 4.97B |
| 53 | RMD | ResMed Inc. | 31.04B | -0.97% | 972,568 | 5.65B |
| 54 | MTD | Mettler-Toledo International Inc. | 30.72B | -0.56% | 196,041 | 4.13B |
| 55 | ALC | Alcon Inc. | 30.11B | -1.77% | 2,391,086 | 10.86B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.97B | 1.84% | 1,356,263 | 4.80B |
| 57 | ZTS | Zoetis Inc. | 29.48B | -0.11% | 3,617,751 | 9.53B |
| 58 | GEHC | GE HealthCare Technologies Inc. | 29.26B | -1.48% | 3,553,175 | 21.27B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.22B | -1.09% | 401,361 | 3.33B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.66B | -0.70% | 4,913,521 | 7.53M |
| 61 | LH | Labcorp Holdings Inc. | 25.28B | 0.99% | 986,830 | 14.35B |
| 62 | DGX | Quest Diagnostics Incorporated | 25.21B | -1.28% | 1,782,145 | 11.56B |
| 63 | BNTX | BioNTech SE | 24.05B | -1.96% | 899,354 | 3.03B |
| 64 | PHG | Koninklijke Philips N.V. | 23.98B | 1.00% | 1,386,586 | 20.18B |
| 65 | UTHR | United Therapeutics Corporation | 23.23B | 0.97% | 518,238 | 3.15B |
| 66 | INSM | Insmed Incorporated | 22.98B | 1.35% | 3,082,091 | 1.14B |
| 67 | GH | Guardant Health, Inc. | 22.91B | -8.83% | 3,386,138 | 1.18B |
| 68 | INCY | Incyte Corporation | 22.85B | -1.23% | 2,459,350 | 5.82B |
| 69 | GMAB | Genmab A/S | 22.35B | -1.77% | 6,595,862 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 20.81B | -0.39% | 426,752 | 21.81B |
| 71 | STE | STERIS plc | 20.34B | -1.15% | 909,383 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.15B | -0.45% | 6,675,645 | 14.74B |
| 73 | RVTY | Revvity, Inc. | 17.11B | -2.58% | 2,678,174 | 2.91B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 17.11B | -2.06% | 1,678,150 | 8.51B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.83B | -2.84% | 219,122 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.03B | -1.94% | 862,149 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 14.85B | -0.87% | 1,091,796 | 1.20B |
| 78 | SOLV | Solventum Corporation | 14.82B | -1.12% | 914,153 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.79B | 0.90% | 1,449,531 | 3.37B |
| 80 | CRL | Charles River Laboratories International, Inc. | 14.56B | -1.87% | 1,923,091 | 4.00B |
| 81 | EXEL | Exelixis, Inc. | 14.45B | -0.88% | 2,031,696 | 2.44B |
| 82 | SMMT | Summit Therapeutics Inc. | 13.81B | 0.23% | 5,872,931 | - |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.28B | 2.82% | 3,118,140 | 14.37B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.09B | 1.24% | 3,709,442 | 713.07M |
| 85 | TEM | Tempus AI, Inc. | 12.99B | -13.85% | 16,541,717 | 1.43B |
| 86 | CORT | Corcept Therapeutics Incorporated | 12.93B | -2.02% | 790,000 | 830.81M |
| 87 | BAX | Baxter International Inc. | 12.59B | 0.58% | 6,523,427 | 11.47B |
| 88 | PEN | Penumbra, Inc. | 12.49B | -0.02% | 308,410 | 1.50B |
| 89 | ICLR | ICON Public Limited Company | 12.48B | -3.92% | 984,006 | 8.29B |
| 90 | HALO | Halozyme Therapeutics, Inc. | 12.45B | 1.30% | 1,768,935 | 1.66B |
| 91 | EHC | Encompass Health Corporation | 12.30B | 3.08% | 1,294,443 | 6.21B |
| 92 | FMS | Fresenius Medical Care AG | 11.87B | -1.02% | 652,444 | 22.19B |
| 93 | DVA | DaVita Inc. | 11.50B | 0.94% | 374,200 | 14.01B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.47B | 0.57% | 330,278 | 1.28B |
| 95 | TECH | Bio-Techne Corporation | 11.36B | -0.21% | 2,893,078 | 1.22B |
| 96 | SNN | Smith & Nephew plc | 11.30B | -0.19% | 1,602,391 | 6.30B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.23B | -0.13% | 7,027,972 | 5.02B |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 10.88B | -2.29% | 3,718,967 | 3.41B |
| 99 | COO | The Cooper Companies, Inc. | 10.73B | -0.60% | 4,003,869 | 4.24B |
| 100 | TXG | 10x Genomics, Inc. | 10.51B | -17.47% | 8,616,854 | 616.91M |
| 101 | TWST | Twist Bioscience Corporation | 10.47B | -18.55% | 7,317,444 | 431.80M |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 10.45B | 1.38% | 3,998,527 | 3.50B |
| 103 | UHS | Universal Health Services, Inc. | 10.44B | 0.59% | 412,370 | 18.11B |
| 104 | AVTR | Avantor, Inc. | 10.44B | -2.40% | 11,387,482 | 6.56B |
| 105 | IBRX | ImmunityBio, Inc. | 10.27B | -6.65% | 16,850,511 | 165.79M |
| 106 | GMED | Globus Medical, Inc. | 10.26B | -0.18% | 1,569,835 | 3.14B |
| 107 | MOH | Molina Healthcare, Inc. | 10.17B | 0.58% | 470,872 | 42.47B |
| 108 | ALGN | Align Technology, Inc. | 10.05B | 0.57% | 1,019,710 | 4.14B |
| 109 | OSCR | Oscar Health, Inc. | 9.97B | -0.25% | 4,215,922 | 15.32B |
| 110 | ENSG | The Ensign Group, Inc. | 9.94B | -0.48% | 416,868 | 5.49B |
| 111 | PCVX | Vaxcyte, Inc. | 9.93B | -9.65% | 10,156,050 | - |
| 112 | RGEN | Repligen Corporation | 9.87B | -7.73% | 1,704,614 | 785.10M |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.86B | -2.89% | 162,233 | 2.59B |
| 114 | KRYS | Krystal Biotech, Inc. | 9.67B | -2.40% | 352,025 | 440.48M |
| 115 | GKOS | Glaukos Corporation | 9.53B | -1.48% | 664,410 | 612.84M |
| 116 | HSIC | Henry Schein, Inc. | 9.46B | 0.72% | 1,421,101 | 13.60B |
| 117 | QGEN | Qiagen N.V. | 9.44B | -0.31% | 2,902,069 | 2.10B |
| 118 | PODD | Insulet Corporation | 9.34B | -0.66% | 1,712,365 | 3.05B |
| 119 | BRKR | Bruker Corporation | 9.22B | -5.26% | 2,903,784 | 3.50B |
| 120 | AXSM | Axsome Therapeutics, Inc. | 9.13B | -1.55% | 1,367,809 | 776.57M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 8.97B | -1.38% | 635,712 | 281.99M |
| 122 | KYMR | Kymera Therapeutics, Inc. | 8.81B | -3.52% | 960,683 | 105.00M |
| 123 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.69B | -1.30% | 1,675,515 | 669.50M |
| 124 | CYTK | Cytokinetics, Incorporated | 8.53B | -2.15% | 3,228,875 | 67.67M |
| 125 | HNGE | Hinge Health, Inc. | 7.94B | - | 2,536,873 | 720.06M |
| 126 | PRAX | Praxis Precision Medicines, Inc. | 7.82B | -1.21% | 435,152 | 7.46M |
| 127 | CAI | Caris Life Sciences, Inc. | 7.76B | -9.66% | 4,747,054 | 989.61M |
| 128 | ATR | AptarGroup, Inc. | 7.65B | -0.30% | 721,517 | 3.93B |
| 129 | ABVX | ABIVAX Société Anonyme | 7.60B | -3.83% | 2,000,517 | 5.33M |
| 130 | HQY | HealthEquity, Inc. | 7.53B | -0.55% | 726,855 | 1.36B |
| 131 | TGTX | TG Therapeutics, Inc. | 7.40B | -3.19% | 2,412,218 | 799.54M |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.31B | 1.15% | 2,241,871 | 874.09M |
| 133 | AMRX | Amneal Pharmaceuticals, Inc. | 7.07B | -0.27% | 3,673,863 | 3.12B |
| 134 | SYRE | Spyre Therapeutics, Inc. | 7.06B | -13.60% | 4,252,295 | - |
| 135 | ALKS | Alkermes plc | 6.99B | -2.60% | 1,545,957 | 1.67B |
| 136 | HIMS | Hims & Hers Health, Inc. | 6.88B | -0.67% | 8,793,711 | 2.58B |
| 137 | PACS | PACS Group, Inc. | 6.78B | 0.23% | 742,988 | 5.55B |
| 138 | GRFS | Grifols, S.A. | 6.78B | 1.48% | 326,097 | 8.48B |
| 139 | IMVT | Immunovant, Inc. | 6.64B | -3.43% | 1,677,070 | - |
| 140 | CHE | Chemed Corporation | 6.64B | -0.29% | 129,125 | 2.60B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.52B | -0.24% | 730,105 | 1.56B |
| 142 | BLTE | Belite Bio, Inc | 6.27B | -2.24% | 190,252 | - |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.25B | -1.82% | 992,869 | 239.92M |
| 144 | BLCO | Bausch + Lomb Corporation | 6.14B | 0.06% | 319,698 | 5.32B |
| 145 | GRAL | GRAIL, Inc. | 6.13B | -10.90% | 2,028,709 | 165.26M |
| 146 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.01B | 1.02% | 378,742 | 840.85M |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 5.92B | -3.20% | 163,739 | 290.54M |
| 148 | IOVA | Iovance Biotherapeutics, Inc. | 5.87B | -8.41% | 17,632,088 | 324.97M |
| 149 | KOD | Kodiak Sciences Inc. | 5.79B | -1.57% | 1,479,583 | - |
| 150 | CGON | CG Oncology, Inc. | 5.64B | -7.38% | 770,729 | 6.23M |
| 151 | RDNT | RadNet, Inc. | 5.53B | -0.41% | 291,655 | 2.27B |
| 152 | MMED | MiniMed Group, Inc. | 5.53B | -2.58% | 13,608,419 | 3.22B |
| 153 | STVN | Stevanato Group S.p.A. | 5.42B | -0.95% | 236,030 | 1.40B |
| 154 | PTCT | PTC Therapeutics, Inc. | 5.32B | 0.08% | 1,270,056 | 1.01B |
| 155 | ORKA | Oruka Therapeutics, Inc. | 5.31B | -4.98% | 1,117,914 | - |
| 156 | TFX | Teleflex Incorporated | 5.29B | -0.40% | 683,314 | 2.25B |
| 157 | TVTX | Travere Therapeutics, Inc. | 5.28B | -2.93% | 1,572,937 | 591.33M |
| 158 | COGT | Cogent Biosciences, Inc. | 5.27B | -1.59% | 2,035,970 | - |
| 159 | CRSP | CRISPR Therapeutics AG | 5.22B | -5.82% | 2,618,034 | 13.39M |
| 160 | SHC | Sotera Health Company | 5.21B | -1.62% | 1,654,087 | 1.22B |
| 161 | SRRK | Scholar Rock Holding Corporation | 5.17B | -2.19% | 1,506,967 | - |
| 162 | MIRM | Mirum Pharmaceuticals, Inc. | 5.15B | -2.68% | 1,146,939 | 618.07M |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.07B | -2.50% | 587,656 | 1.58B |
| 164 | WAY | Waystar Holding Corp. | 5.06B | -0.30% | 1,960,143 | 1.21B |
| 165 | ERAS | Erasca, Inc. | 5.00B | -2.85% | 8,043,031 | - |
| 166 | DOCS | Doximity, Inc. | 4.95B | -2.76% | 2,308,164 | 655.57M |
| 167 | DFTX | Definium Therapeutics, Inc. | 4.79B | -1.68% | 2,474,232 | - |
| 168 | DNTH | Dianthus Therapeutics, Inc. | 4.78B | -3.00% | 1,347,574 | 1.90M |
| 169 | BLLN | BillionToOne, Inc. | 4.72B | -8.36% | 1,117,652 | 397.41M |
| 170 | HAE | Haemonetics Corporation | 4.71B | -1.11% | 542,039 | 1.35B |
| 171 | OPCH | Option Care Health, Inc. | 4.64B | 32.65% | 65,073,155 | 5.69B |
| 172 | CON | Concentra Group Holdings Parent, Inc. | 4.64B | 0.52% | 906,414 | 2.29B |
| 173 | LFST | LifeStance Health Group, Inc. | 4.63B | -0.82% | 2,495,942 | 1.58B |
| 174 | MANE | Veradermics, Incorporated | 4.55B | -8.34% | 736,631 | - |
| 175 | HTFL | HeartFlow, Inc. | 4.41B | -2.91% | 2,393,443 | 212.07M |
| 176 | EWTX | Edgewise Therapeutics, Inc. | 4.35B | -0.69% | 1,624,858 | - |
| 177 | ITGR | Integer Holdings Corporation | 4.30B | 0.02% | 311,841 | 1.84B |
| 178 | ADPT | Adaptive Biotechnologies Corporation | 4.29B | -9.85% | 2,533,190 | 308.08M |
| 179 | ABCL | AbCellera Biologics Inc. | 4.26B | -4.57% | 9,781,642 | 66.17M |
| 180 | INDV | Indivior Pharmaceuticals, Inc. | 4.24B | -0.25% | 2,390,473 | 1.33B |
| 181 | LIVN | LivaNova PLC | 4.13B | -1.96% | 424,528 | 1.47B |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.11B | -3.35% | 3,203,908 | 10.35M |
| 183 | ICUI | ICU Medical, Inc. | 3.99B | -1.03% | 238,610 | 2.16B |
| 184 | NVST | Envista Holdings Corporation | 3.74B | -0.30% | 1,838,678 | 2.86B |
| 185 | TNGX | Tango Therapeutics, Inc. | 3.69B | -5.11% | 4,351,003 | 53.81M |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.66B | -0.92% | 231,700 | 890.79M |
| 187 | RGC | Regencell Bioscience Holdings Limited | 3.64B | 1.52% | 300,671 | - |
| 188 | LEGN | Legend Biotech Corporation | 3.63B | -0.29% | 1,340,306 | 1.27B |
| 189 | OGN | Organon & Co. | 3.61B | 0.29% | 1,948,898 | 6.13B |
| 190 | VCYT | Veracyte, Inc. | 3.59B | -6.34% | 1,730,811 | 561.90M |
| 191 | NHC | National HealthCare Corporation | 3.58B | -0.91% | 90,576 | 1.56B |
| 192 | PBLS | Parabilis Medicines, Inc. | 3.57B | -2.27% | 979,192 | 148.00K |
| 193 | PLSE | Pulse Biosciences, Inc. | 3.55B | -1.49% | 421,363 | 1.19M |
| 194 | XENE | Xenon Pharmaceuticals Inc. | 3.54B | -2.66% | 2,787,290 | 7.50M |
| 195 | IDYA | IDEAYA Biosciences, Inc. | 3.53B | -3.76% | 802,450 | 234.13M |
| 196 | IRTC | iRhythm Holdings, Inc. | 3.53B | -1.73% | 418,385 | 825.34M |
| 197 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.52B | 0.94% | 1,279,348 | -665.00K |
| 198 | CELC | Celcuity Inc. | 3.49B | -3.22% | 1,563,195 | - |
| 199 | ACAD | Acadia Pharmaceuticals Inc. | 3.40B | -1.84% | 1,659,490 | 1.14B |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.31B | -3.07% | 7,096,557 | - |
| 201 | CDNA | CareDx, Inc. | 3.30B | -8.68% | 2,226,881 | 458.09M |
| 202 | TARS | Tarsus Pharmaceuticals, Inc. | 3.25B | -0.46% | 432,421 | 606.33M |
| 203 | WRBY | Warby Parker Inc. | 3.24B | -1.58% | 3,253,419 | 911.61M |
| 204 | ELVN | Enliven Therapeutics, Inc. | 3.11B | -6.77% | 2,330,171 | - |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.09B | -1.86% | 824,848 | 117.00M |
| 206 | DNLI | Denali Therapeutics Inc. | 3.08B | -3.16% | 3,674,353 | 3.60M |
| 207 | ARQT | Arcutis Biotherapeutics, Inc. | 3.01B | -4.89% | 2,471,399 | 463.98M |
| 208 | DYN | Dyne Therapeutics, Inc. | 2.88B | -0.26% | 4,098,723 | - |
| 209 | ZLAB | Zai Lab Limited | 2.87B | -0.16% | 1,214,217 | 449.61M |
| 210 | TMDX | TransMedics Group, Inc. | 2.78B | -3.27% | 570,619 | 668.47M |
| 211 | MBX | MBX Biosciences, Inc. | 2.74B | -2.77% | 366,621 | - |
| 212 | ATRC | AtriCure, Inc. | 2.73B | -4.77% | 863,659 | 569.62M |
| 213 | ACHC | Acadia Healthcare Company, Inc. | 2.70B | 0.59% | 1,417,726 | 3.37B |
| 214 | PGEN | Precigen, Inc. | 2.70B | -2.45% | 4,669,002 | 85.72M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.67B | -1.21% | 3,304,338 | 2.60B |
| 216 | NAMS | NewAmsterdam Pharma Company N.V. | 2.66B | -2.32% | 1,266,231 | 7.12M |
| 217 | HCM | HUTCHMED (China) Limited | 2.61B | 2.41% | 68,469 | 549.12M |
| 218 | GRDN | Guardian Pharmacy Services, Inc. | 2.61B | -2.14% | 388,561 | 1.46B |
| 219 | NEOG | Neogen Corporation | 2.61B | -8.07% | 5,923,631 | 884.00M |
| 220 | BKD | Brookdale Senior Living Inc. | 2.60B | 3.51% | 4,574,438 | 2.93B |
| 221 | PRVA | Privia Health Group, Inc. | 2.59B | -0.83% | 1,078,688 | 2.36B |
| 222 | BEAM | Beam Therapeutics Inc. | 2.52B | -1.71% | 2,516,705 | 156.04M |
| 223 | SUPN | Supernus Pharmaceuticals, Inc. | 2.49B | 0.16% | 748,262 | 830.44M |
| 224 | RXRX | Recursion Pharmaceuticals, Inc. | 2.48B | -3.14% | 69,401,228 | 54.86M |
| 225 | CLOV | Clover Health Investments, Corp. | 2.44B | -1.71% | 3,350,490 | 2.48B |
| 226 | CLDX | Celldex Therapeutics, Inc. | 2.43B | -4.86% | 1,769,432 | 158.00K |
| 227 | IRON | Disc Medicine, Inc. | 2.37B | -2.65% | 1,343,053 | - |
| 228 | UFPT | UFP Technologies, Inc. | 2.35B | -1.45% | 132,592 | 631.64M |
| 229 | NRIX | Nurix Therapeutics, Inc. | 2.35B | -1.22% | 1,154,217 | 36.77M |
| 230 | LQDA | Liquidia Corporation | 2.32B | -6.26% | 4,714,116 | 450.91M |
| 231 | BFLY | Butterfly Network, Inc. | 2.32B | -7.25% | 8,750,927 | 112.14M |
| 232 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | -1.40% | 507,275 | 959.90M |
| 233 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -2.49% | 3,951,084 | - |
| 234 | ADMA | ADMA Biologics, Inc. | 2.28B | 0.69% | 2,100,139 | 512.28M |
| 235 | BHC | Bausch Health Companies Inc. | 2.25B | 2.21% | 2,991,103 | 10.85B |
| 236 | ALMR | Alamar Biosciences, Inc. | 2.24B | -15.39% | 1,146,165 | 100.42M |
| 237 | PBH | Prestige Consumer Healthcare Inc. | 2.20B | 1.84% | 658,601 | 1.10B |
| 238 | IMNM | Immunome, Inc. | 2.19B | -8.79% | 2,177,268 | 4.02M |
| 239 | ALVO | Alvotech | 2.19B | 0.49% | 1,218,210 | 494.61M |
| 240 | PHVS | Pharvaris N.V. | 2.18B | 2.07% | 778,341 | - |
| 241 | SDGR | Schrödinger, Inc. | 2.16B | -11.35% | 5,262,569 | 259.04M |
| 242 | WGS | GeneDx Holdings Corp. | 2.13B | -6.23% | 816,606 | 454.43M |
| 243 | AXGN | Axogen, Inc. | 2.13B | -2.44% | 2,354,739 | 251.17M |
| 244 | NEO | NeoGenomics, Inc. | 2.12B | -13.72% | 4,774,727 | 766.30M |
| 245 | VERA | Vera Therapeutics, Inc. | 2.12B | -1.37% | 2,395,793 | - |
| 246 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -0.19% | 591,672 | 311.51M |
| 247 | ADRX | ADARx Pharmaceuticals, Inc. | 2.08B | -2.47% | 1,034,911 | 6.13M |
| 248 | ADUS | Addus HomeCare Corporation | 2.07B | 0.16% | 125,548 | 1.48B |
| 249 | VRDN | Viridian Therapeutics, Inc. | 2.06B | -4.11% | 2,195,834 | 71.13M |
| 250 | MD | Pediatrix Medical Group, Inc. | 2.06B | -0.38% | 667,744 | 1.95B |
| 251 | VCEL | Vericel Corporation | 2.05B | -2.48% | 669,041 | 306.30M |
| 252 | TRLV | Trulieve Cannabis Corp. | 2.05B | - | 1,154,900 | 1.14B |
| 253 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.04B | -7.86% | 3,613,103 | 208.78M |
| 254 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.03B | -1.85% | 3,939,383 | 940.61M |
| 255 | URGN | UroGen Pharma Ltd. | 2.03B | -3.16% | 764,453 | 188.73M |
| 256 | PGNY | Progyny, Inc. | 1.99B | 0.19% | 868,320 | 1.31B |
| 257 | FTRE | Fortrea Holdings Inc. | 1.98B | -1.56% | 2,650,557 | 2.68B |
| 258 | INSP | Inspire Medical Systems, Inc. | 1.97B | -3.60% | 869,546 | 898.74M |
| 259 | VIR | Vir Biotechnology, Inc. | 1.96B | -1.53% | 2,174,112 | 303.23M |
| 260 | GPCR | Structure Therapeutics Inc. | 1.96B | -0.43% | 1,168,990 | - |
| 261 | ESTA | Establishment Labs Holdings Inc. | 1.95B | -1.78% | 446,532 | 245.82M |
| 262 | PRGO | Perrigo Company plc | 1.94B | -3.05% | 2,035,376 | 4.14B |
| 263 | MLYS | Mineralys Therapeutics, Inc. | 1.94B | -5.79% | 1,215,341 | - |
| 264 | LKFT | Lakefront Biotherapeutics NV | 1.93B | -0.64% | 452,117 | 1.13B |
| 265 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 1.50% | 1,278,349 | 98.34M |
| 266 | ASTH | Astrana Health, Inc. | 1.89B | 0.52% | 227,128 | 3.84B |
| 267 | BLFS | BioLife Solutions, Inc. | 1.89B | - | - | 106.69M |
| 268 | TRVI | Trevi Therapeutics, Inc. | 1.88B | -3.94% | 1,841,645 | - |
| 269 | NVAX | Novavax, Inc. | 1.87B | -9.87% | 18,798,896 | 413.80M |
| 270 | PVLA | Palvella Therapeutics, Inc. | 1.84B | -3.15% | 309,383 | - |
| 271 | XERS | Xeris Biopharma Holdings, Inc. | 1.84B | -0.59% | 2,139,843 | 335.41M |
| 272 | SRPT | Sarepta Therapeutics, Inc. | 1.83B | -1.03% | 2,690,374 | 1.97B |
| 273 | BHVN | Biohaven Ltd. | 1.82B | -6.86% | 2,500,173 | - |
| 274 | ZYME | Zymeworks Inc. | 1.82B | -2.14% | 1,465,970 | 37.13M |
| 275 | XNCR | Xencor, Inc. | 1.81B | -4.96% | 1,245,797 | 104.97M |
| 276 | LMAT | LeMaitre Vascular, Inc. | 1.81B | -2.40% | 202,066 | 262.43M |
| 277 | GENB | Generate Biomedicines, Inc. | 1.77B | -0.79% | 1,169,764 | 26.48M |
| 278 | ABSI | Absci Corporation | 1.76B | -10.93% | 5,876,168 | 1.56M |
| 279 | SNDA | Sonida Senior Living, Inc. | 1.76B | 1.09% | 367,921 | 481.07M |
| 280 | FRNM | Freenome, Inc. | 1.76B | -2.79% | 712,304 | 35.41M |
| 281 | ZBIO | Zenas BioPharma, Inc. | 1.76B | -3.20% | 357,574 | 1.00M |
| 282 | NVCR | NovoCure Limited | 1.74B | -1.51% | 1,749,178 | 699.19M |
| 283 | SGRY | Surgery Partners, Inc. | 1.74B | 0.60% | 892,285 | 3.37B |
| 284 | ALHC | Alignment Healthcare, Inc. | 1.74B | -1.53% | 10,761,086 | 4.58B |
| 285 | NTLA | Intellia Therapeutics, Inc. | 1.73B | -2.98% | 7,949,135 | 59.51M |
| 286 | AZTA | Azenta, Inc. | 1.72B | -7.91% | 2,545,963 | 613.81M |
| 287 | NUVB | Nuvation Bio Inc. | 1.71B | -1.41% | 6,653,303 | 169.90M |
| 288 | PSNL | Personalis, Inc. | 1.71B | -2.26% | 5,659,788 | 69.67M |
| 289 | MESO | Mesoblast Limited | 1.71B | -4.29% | 403,817 | 120.25M |
| 290 | XRAY | DENTSPLY SIRONA Inc. | 1.70B | -0.47% | 4,713,847 | 3.64B |
| 291 | SEPN | Septerna, Inc. | 1.66B | -5.81% | 489,258 | 98.88M |
| 292 | BRVE | Braveheart Bio, Inc. | 1.63B | -7.31% | 590,321 | - |
| 293 | ATEC | Alphatec Holdings, Inc. | 1.63B | -1.68% | 1,908,050 | 815.05M |
| 294 | OMCL | Omnicell, Inc. | 1.62B | 2.37% | 634,244 | 1.25B |
| 295 | KMTS | Kestra Medical Technologies, Ltd. | 1.61B | -4.38% | 208,489 | 106.73M |
| 296 | OCUL | Ocular Therapeutix, Inc. | 1.61B | 1.24% | 2,806,885 | 52.06M |
| 297 | CMPS | COMPASS Pathways plc | 1.60B | -0.34% | 2,562,767 | - |
| 298 | QURE | uniQure N.V. | 1.60B | 1.14% | 2,788,741 | 18.67M |
| 299 | AAPG | Ascentage Pharma Group International | 1.59B | 10.17% | 14,173 | 94.61M |
| 300 | STOK | Stoke Therapeutics, Inc. | 1.57B | -3.75% | 1,167,304 | 27.59M |
| 301 | ETON | Eton Pharmaceuticals, Inc. | 1.57B | -1.53% | 492,343 | 105.60M |
| 302 | SNDX | Syndax Pharmaceuticals, Inc. | 1.55B | -2.58% | 1,135,132 | 252.25M |
| 303 | ANIP | ANI Pharmaceuticals, Inc. | 1.53B | -1.46% | 291,997 | 978.38M |
| 304 | IMCR | Immunocore Holdings plc | 1.53B | 0.17% | 662,603 | 430.78M |
| 305 | ARDT | Ardent Health, Inc. | 1.51B | 1.23% | 270,064 | 6.41B |
| 306 | INVA | Innoviva, Inc. | 1.50B | 0.92% | 679,577 | 440.00M |
| 307 | NUTX | Nutex Health Inc. | 1.50B | -2.93% | 122,455 | 846.72M |
| 308 | RAPP | Rapport Therapeutics, Inc. | 1.49B | -3.23% | 235,641 | 20.00M |
| 309 | PAHC | Phibro Animal Health Corporation | 1.49B | -1.56% | 133,227 | 1.52B |
| 310 | GHRS | GH Research PLC | 1.48B | -2.93% | 495,404 | - |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.47B | - | 531,909 | 20.00M |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.45B | -0.28% | 562,669 | 1.86B |
| 313 | KRSA | Korsana Biosciences, Inc. | 1.44B | 2.70% | 41,974 | - |
| 314 | ANAB | AnaptysBio, Inc. | 1.43B | -2.66% | 627,088 | 106.09M |
| 315 | TSHA | Taysha Gene Therapies, Inc. | 1.43B | -2.23% | 4,833,713 | 5.49M |
| 316 | AMN | AMN Healthcare Services, Inc. | 1.42B | -0.30% | 670,738 | 3.43B |
| 317 | RARE | Ultragenyx Pharmaceutical Inc. | 1.42B | -0.28% | 3,891,953 | 717.00M |
| 318 | CERT | Certara, Inc. | 1.41B | -7.94% | 3,946,115 | 421.75M |
| 319 | KLRA | Kailera Therapeutics, Inc. | 1.40B | -0.09% | 1,452,009 | - |
| 320 | AGL | agilon health, inc. | 1.40B | -1.04% | 169,829 | 5.92B |
| 321 | PNTG | The Pennant Group, Inc. | 1.40B | -0.86% | 236,298 | 1.10B |
| 322 | TYRA | Tyra Biosciences, Inc. | 1.39B | -3.30% | 761,602 | - |
| 323 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -1.22% | 169,388 | 1.30M |
| 324 | NKTR | Nektar Therapeutics | 1.36B | -5.47% | 1,661,865 | 54.59M |
| 325 | OMER | Omeros Corporation | 1.34B | -2.06% | 1,034,956 | 38.42M |
| 326 | DRTS | Alpha Tau Medical Ltd. | 1.34B | -2.75% | 380,903 | - |
| 327 | CNMD | CONMED Corporation | 1.33B | -6.02% | 456,365 | 1.37B |
| 328 | COAG | Hemab Therapeutics Holdings, Inc. | 1.33B | -7.26% | 436,821 | - |
| 329 | NBTX | Nanobiotix S.A. | 1.32B | 1.95% | 156,298 | 13.15M |
| 330 | OMDA | Omada Health, Inc. | 1.27B | -1.05% | 734,702 | 309.76M |
| 331 | KARD | Kardigan, Inc. | 1.26B | -11.48% | 1,560,895 | - |
| 332 | REPL | Replimune Group, Inc. | 1.25B | 0.76% | 2,616,965 | - |
| 333 | USPH | U.S. Physical Therapy, Inc. | 1.25B | -0.39% | 186,206 | 804.27M |
| 334 | ORIC | ORIC Pharmaceuticals, Inc. | 1.24B | -4.08% | 1,902,154 | - |
| 335 | INNV | InnovAge Holding Corp. | 1.23B | - | 362,370 | 989.71M |
| 336 | CRON | Cronos Group Inc. | 1.22B | 1.08% | 677,768 | 179.09M |
| 337 | DMRA | Damora Therapeutics, Inc. | 1.21B | -3.31% | 1,113,049 | - |
| 338 | MNKD | MannKind Corporation | 1.19B | -2.88% | 2,119,242 | 393.63M |
| 339 | SVRA | Savara Inc. | 1.18B | -2.72% | 2,289,344 | - |
| 340 | HROW | Harrow, Inc. | 1.14B | -0.75% | 421,667 | 275.59M |
| 341 | AVLN | Avalyn Pharma Inc. | 1.13B | -5.92% | 260,609 | - |
| 342 | TNDM | Tandem Diabetes Care, Inc. | 1.12B | -2.18% | 1,484,876 | 1.04B |
| 343 | TRAX | First Tracks Biotherapeutics, Inc. | 1.12B | -4.85% | 612,166 | - |
| 344 | GDRX | GoodRx Holdings, Inc. | 1.12B | -2.68% | 489,254 | 785.23M |
| 345 | STAA | STAAR Surgical Company | 1.11B | -1.86% | 635,993 | 339.59M |
| 346 | LBRX | LB Pharmaceuticals Inc | 1.11B | -1.04% | 432,764 | - |
| 347 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.10B | 2.13% | 469,145 | 730.02M |
| 348 | BVS | Bioventus Inc. | 1.10B | -3.11% | 230,295 | 581.85M |
| 349 | BCAX | Bicara Therapeutics Inc. | 1.10B | -4.22% | 981,196 | - |
| 350 | OPK | OPKO Health, Inc. | 1.09B | -7.01% | 2,452,761 | 587.90M |
| 351 | IRMD | IRADIMED CORPORATION | 1.08B | -1.91% | 118,605 | 86.34M |
| 352 | VOR | Vor Biopharma Inc. | 1.08B | -1.45% | 472,841 | - |
| 353 | LTGO | Latigo Biotherapeutics, Inc. | 1.08B | -2.22% | 544,509 | - |
| 354 | AORT | Artivion, Inc. | 1.06B | -3.41% | 494,349 | 471.47M |
| 355 | ENOV | Enovis Corporation | 1.05B | -2.62% | 1,017,538 | 2.30B |
| 356 | TDOC | Teladoc Health, Inc. | 1.05B | -0.35% | 3,724,496 | 2.49B |
| 357 | CGEM | Cullinan Therapeutics, Inc. | 1.05B | 1.31% | 2,017,007 | - |
| 358 | IART | Integra LifeSciences Holdings Corporation | 1.04B | 0.23% | 1,107,769 | 1.65B |
| 359 | IMTX | Immatics N.V. | 1.03B | -2.98% | 974,370 | 47.65M |
| 360 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | -0.56% | 258,120 | 1.04B |
| 361 | JANX | Janux Therapeutics, Inc. | 1.03B | 1.63% | 807,550 | 24.00M |
| 362 | CSTL | Castle Biosciences, Inc. | 1.02B | -8.98% | 536,764 | 357.28M |
| 363 | MGTX | MeiraGTx Holdings plc | 1.02B | -2.93% | 944,435 | 397.50M |
| 364 | PRCT | PROCEPT BioRobotics Corporation | 1.00B | -1.74% | 949,307 | 337.34M |
| 365 | AHG | Akso Health Group | 1.00B | 0.86% | 19,727 | 13.83M |
| 366 | AKTS | Aktis Oncology, Inc. | 993.36M | -3.56% | 294,761 | 10.06M |
| 367 | PCRX | Pacira BioSciences, Inc. | 986.98M | -1.16% | 493,119 | 746.16M |
| 368 | BBNX | Beta Bionics, Inc. | 980.72M | -1.69% | 517,823 | 119.01M |
| 369 | HSTM | HealthStream, Inc. | 957.96M | -0.73% | 182,880 | 321.12M |
| 370 | KURA | Kura Oncology, Inc. | 936.76M | -0.85% | 1,298,218 | 77.23M |
| 371 | CBLL | CeriBell, Inc. | 934.12M | -2.09% | 241,738 | 101.96M |
| 372 | MLTX | MoonLake Immunotherapeutics | 931.92M | -3.78% | 3,051,135 | - |
| 373 | ANL | Adlai Nortye Group Ltd. | 931.19M | -3.86% | 99,765 | 18.06M |
| 374 | SPTX | Seaport Therapeutics, Inc. | 929.83M | -6.11% | 243,003 | - |
| 375 | ANRO | Alto Neuroscience, Inc. | 929.65M | -1.33% | 576,283 | - |
| 376 | ALMS | Alumis Inc. | 896.99M | 1.32% | 1,745,517 | 7.40M |
| 377 | CRVS | Corvus Pharmaceuticals, Inc. | 887.48M | -1.77% | 1,438,007 | - |
| 378 | ABUS | Arbutus Biopharma Corporation | 886.36M | -4.07% | 8,259,925 | 181.72M |
| 379 | SIBN | SI-BONE, Inc. | 876.20M | -1.31% | 538,729 | 213.60M |
| 380 | ODTX | Odyssey Therapeutics, Inc. | 868.76M | -13.00% | 340,661 | 99.00K |
| 381 | SLBT | SL Science Holding Limited | 866.80M | -4.40% | 52,201 | 3.27M |
| 382 | QDEL | QuidelOrtho Corporation | 861.99M | 3.54% | 3,218,409 | 2.67B |
| 383 | RIGL | Rigel Pharmaceuticals, Inc. | 861.33M | -3.52% | 202,597 | 276.79M |
| 384 | JBIO | Jade Biosciences, Inc. | 852.84M | -4.69% | 493,858 | - |
| 385 | GLUE | Monte Rosa Therapeutics, Inc. | 842.04M | -3.89% | 1,052,771 | 28.73M |
| 386 | PACB | Pacific Biosciences of California, Inc. | 839.24M | -5.92% | 47,081,651 | 159.27M |
| 387 | DNA | Ginkgo Bioworks Holdings, Inc. | 835.69M | -17.16% | 12,872,608 | 132.42M |
| 388 | SGP | SpyGlass Pharma, Inc. | 828.84M | -3.17% | 81,204 | - |
| 389 | ARDX | Ardelyx, Inc. | 824.81M | -2.36% | 5,815,828 | 450.89M |
| 390 | SANA | Sana Biotechnology, Inc. | 823.24M | -4.51% | 3,353,405 | - |
| 391 | OBX | Obsidian Therapeutics, Inc. | 816.64M | -4.48% | 288,794 | - |
| 392 | INMD | InMode Ltd. | 804.16M | -0.99% | 538,125 | 374.63M |
| 393 | ATTO | Attovia Therapeutics, Inc. | 801.18M | -2.47% | 521,651 | 1.80M |
| 394 | IMMX | Immix Biopharma, Inc. | 799.18M | -4.84% | 1,214,627 | - |
| 395 | GMRS | GMR Solutions Inc. | 792.76M | 2.20% | 826,268 | 5.88B |
| 396 | HELP | Helus Pharma Inc. | 786.13M | -5.78% | 1,476,612 | - |
| 397 | IVA | Inventiva S.A. | 784.66M | -0.57% | 2,200,248 | 2.81M |
| 398 | VREX | Varex Imaging Corporation | 778.89M | 0.16% | 265,685 | 865.00M |
| 399 | LXRX | Lexicon Pharmaceuticals, Inc. | 778.67M | 0.57% | 1,358,435 | 41.47M |
| 400 | GERN | Geron Corporation | 777.39M | - | 5,717,917 | 204.56M |
| 401 | APMD | Apnimed, Inc. | 776.41M | -14.25% | 557,898 | 115.12M |
| 402 | AHCO | AdaptHealth Corp. | 769.77M | 0.52% | 2,529,965 | 3.36B |
| 403 | ANNX | Annexon, Inc. | 764.00M | -4.05% | 2,701,298 | - |
| 404 | CADL | Candel Therapeutics, Inc. | 755.24M | -3.52% | 976,050 | - |
| 405 | GYRE | Gyre Therapeutics, Inc. | 750.72M | -3.67% | 133,969 | 109.82M |
| 406 | DSGN | Design Therapeutics, Inc. | 749.10M | -3.62% | 642,530 | - |
| 407 | AVBP | ArriVent BioPharma, Inc. | 744.05M | -46.98% | 19,743,236 | - |
| 408 | SLDB | Solid Biosciences Inc. | 742.00M | -1.98% | 1,184,966 | - |
| 409 | AVTX | Avalo Therapeutics, Inc. | 728.83M | -6.92% | 955,554 | 59.00K |
| 410 | ACHV | Achieve Life Sciences, Inc. | 723.40M | 0.29% | 1,056,364 | - |
| 411 | COLL | Collegium Pharmaceutical, Inc. | 712.32M | 0.05% | 634,060 | 808.21M |
| 412 | VSTM | Verastem, Inc. | 701.87M | -3.13% | 2,277,195 | 87.53M |
| 413 | CTKB | Cytek Biosciences, Inc. | 699.31M | -11.66% | 2,045,815 | 206.71M |
| 414 | FTH | Faeth Therapeutics, Inc. | 694.85M | -0.77% | 289,139 | - |
| 415 | FDMT | 4D Molecular Therapeutics, Inc. | 693.87M | -2.79% | 1,168,618 | 92.01M |
| 416 | WVE | Wave Life Sciences, Inc. | 693.61M | -6.13% | 3,449,746 | 65.37M |
| 417 | OLMA | Olema Pharmaceuticals, Inc. | 692.98M | -4.00% | 1,038,936 | - |
| 418 | AVR | Anteris Technologies Global Corp. | 687.33M | -6.62% | 2,641,733 | 2.24M |
| 419 | PHAR | Pharming Group N.V. | 683.13M | -0.66% | 6,726 | 366.48M |
| 420 | MDXG | MiMedx Group, Inc. | 673.41M | 1.54% | 1,050,117 | 355.17M |
| 421 | STLN | Starling Oncology, Inc. | 670.61M | 4.44% | 985,793 | 587.24M |
| 422 | NVCT | Nuvectis Pharma, Inc. | 652.61M | -6.36% | 188,080 | - |
| 423 | AURA | Aura Biosciences, Inc. | 639.86M | -0.80% | 607,488 | - |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 637.19M | 0.28% | 614,550 | 136.07M |
| 425 | PHR | Phreesia, Inc. | 636.23M | -1.16% | 605,062 | 507.79M |
| 426 | OABI | OmniAb, Inc. | 632.45M | -11.59% | 2,002,165 | 38.46M |
| 427 | SOPH | SOPHiA GENETICS SA | 628.24M | -10.00% | 926,586 | 86.17M |
| 428 | PRME | Prime Medicine, Inc. | 622.67M | 9.03% | 12,013,972 | 4.07M |
| 429 | ETRA | Electra Therapeutics, Inc. | 622.02M | 1.75% | 276,154 | - |
| 430 | SGMT | Sagimet Biosciences Inc. | 621.16M | -2.99% | 896,335 | - |
| 431 | CLYM | Climb Bio, Inc. | 613.42M | -3.35% | 953,621 | - |
| 432 | IRWD | Ironwood Pharmaceuticals, Inc. | 599.82M | -0.55% | 1,866,693 | 389.32M |
| 433 | ANGO | AngioDynamics, Inc. | 596.01M | -7.21% | 847,545 | 320.17M |
| 434 | KIDS | OrthoPediatrics Corp. | 592.95M | -0.79% | 236,394 | 252.72M |
| 435 | SLN | Silence Therapeutics plc | 591.86M | -3.06% | 1,583,355 | 615.00K |
| 436 | WEAV | Weave Communications, Inc. | 590.39M | 0.27% | 789,052 | 257.79M |
| 437 | STTK | Shattuck Labs, Inc. | 588.13M | -9.85% | 1,595,350 | 1.00M |
| 438 | CBIO | Crescent Biopharma, Inc. | 580.81M | -2.65% | 492,370 | 11.88M |
| 439 | AQST | Aquestive Therapeutics, Inc. | 578.61M | 0.88% | 1,208,142 | 54.09M |
| 440 | EVO | Evotec SE | 577.66M | -1.81% | 189,972 | 819.47M |
| 441 | CRMD | CorMedix Inc. | 567.43M | 0.28% | 744,254 | 462.25M |
| 442 | FLGT | Fulgent Genetics, Inc. | 566.26M | -8.33% | 368,607 | 323.93M |
| 443 | DBVT | DBV Technologies S.A. | 563.79M | -4.50% | 558,006 | 5.04M |
| 444 | SSII | SS Innovations International, Inc. | 559.08M | 0.72% | 54,811 | 52.40M |
| 445 | CTMX | CytomX Therapeutics, Inc. | 557.82M | -0.78% | 1,615,428 | 18.30M |
| 446 | BLSM | BlossomHill Therapeutics, Inc. | 549.56M | -13.29% | 247,353 | - |
| 447 | VALN | Valneva SE | 547.05M | 0.60% | 19,055 | 163.30M |
| 448 | ACRS | Aclaris Therapeutics, Inc. | 544.64M | -13.35% | 3,530,282 | 8.22M |
| 449 | PHAT | Phathom Pharmaceuticals, Inc. | 538.54M | 1.19% | 2,085,339 | 239.66M |
| 450 | MPLT | MapLight Therapeutics, Inc. | 538.53M | 4.47% | 495,587 | - |
| 451 | OCS | Oculis Holding AG | 535.22M | 1.29% | 291,638 | 1.45M |
| 452 | DCTH | Delcath Systems, Inc. | 534.71M | -2.90% | 244,817 | 95.42M |
| 453 | MNPR | Monopar Therapeutics Inc. | 534.09M | 1.63% | 301,958 | - |
| 454 | SENS | Senseonics Holdings, Inc. | 526.63M | -3.39% | 568,651 | 48.55M |
| 455 | ALT | Altimmune, Inc. | 519.36M | - | 7,623,147 | 31.00K |
| 456 | TLRY | Tilray Brands, Inc. | 517.83M | 1.61% | 3,630,405 | 915.45M |
| 457 | MASS | 908 Devices Inc. | 509.64M | -3.67% | 377,273 | 60.84M |
| 458 | NGNE | Neurogene Inc. | 509.29M | -3.85% | 121,647 | 925.00K |
| 459 | EPRX | Eupraxia Pharmaceuticals Inc. | 508.19M | -0.06% | 1,636,357 | - |
| 460 | ALLO | Allogene Therapeutics, Inc. | 504.42M | -2.67% | 4,370,356 | 4.64M |
| 461 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 462 | TCMD | Tactile Systems Technology, Inc. | 502.65M | -1.25% | 148,570 | 350.31M |
| 463 | RGNX | REGENXBIO Inc. | 491.80M | -3.99% | 1,161,216 | 174.48M |
| 464 | PBYI | Puma Biotechnology, Inc. | 490.39M | -1.76% | 203,862 | 231.24M |
| 465 | EOLS | Evolus, Inc. | 487.45M | -1.20% | 663,881 | 316.49M |
| 466 | GLAS | Glass House Brands Inc. | 486.29M | -3.55% | 2,042,909 | 176.98M |
| 467 | PROK | ProKidney Corp. | 483.72M | 1.27% | 770,563 | 818.00K |
| 468 | BWAY | BrainsWay Ltd. | 480.65M | -2.78% | 143,561 | 60.70M |
| 469 | DRUG | Bright Minds Biosciences Inc. | 480.02M | -3.09% | 56,983 | - |
| 470 | ARVN | Arvinas, Inc. | 477.97M | -2.01% | 584,794 | 316.70M |
| 471 | AUTL | Autolus Therapeutics plc | 476.43M | -2.19% | 1,682,519 | 117.39M |
| 472 | CTNM | Contineum Therapeutics, Inc. | 475.91M | -0.55% | 761,921 | - |
| 473 | CERS | Cerus Corporation | 471.57M | - | 1,483,760 | 221.55M |
| 474 | SGHT | Sight Sciences, Inc. | 471.55M | -4.04% | 316,690 | 83.38M |
| 475 | TKNO | Alpha Teknova, Inc. | 469.77M | -2.78% | 376,961 | 43.70M |
| 476 | KMDA | Kamada Ltd. | 465.79M | 1.37% | 146,653 | 191.85M |
| 477 | OVID | Ovid Therapeutics Inc. | 462.86M | 1.28% | 1,735,012 | 1.58M |
| 478 | RZLT | Rezolute, Inc. | 453.15M | -0.23% | 2,191,785 | - |
| 479 | ASMB | Assembly Biosciences, Inc. | 451.60M | -2.46% | 195,859 | 74.85M |
| 480 | CAPR | Capricor Therapeutics, Inc. | 450.58M | -0.39% | 3,127,345 | 11.13M |
| 481 | NRC | NRC Health | 444.16M | -3.37% | 80,013 | 140.00M |
| 482 | DMAC | DiaMedica Therapeutics Inc. | 438.42M | -3.44% | 218,626 | - |
| 483 | TECX | Tectonic Therapeutic, Inc. | 438.10M | -3.03% | 200,364 | - |
| 484 | ENTX | Entera Bio Ltd. | 438.05M | -3.44% | 621,166 | 42.00K |
| 485 | AGMB | AgomAb Therapeutics NV | 436.34M | 1.96% | 103,920 | - |
| 486 | YDES | YD Bio Limited | 435.61M | -13.50% | 439,652 | 1.24M |
| 487 | NPCE | NeuroPace, Inc. | 434.89M | -4.16% | 82,987 | 106.99M |
| 488 | EVH | Evolent Health, Inc. | 434.15M | 6.37% | 1,584,505 | 2.10B |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 427.13M | 0.12% | 1,216,161 | 116.93M |
| 490 | SRTA | Strata Critical Medical, Inc. | 420.22M | -1.25% | 760,505 | 255.98M |
| 491 | EDIT | Editas Medicine, Inc. | 419.27M | -2.15% | 2,771,004 | 47.01M |
| 492 | PRTA | Prothena Corporation plc | 411.72M | -3.02% | 508,306 | 54.53M |
| 493 | MYGN | Myriad Genetics, Inc. | 409.38M | -6.55% | 1,797,080 | 806.60M |
| 494 | CTEV | Claritev Corporation | 408.26M | -2.39% | 188,976 | 994.67M |
| 495 | EIKN | Eikon Therapeutics, Inc. | 406.78M | -0.40% | 609,220 | - |
| 496 | AVIR | Atea Pharmaceuticals, Inc. | 406.64M | -1.17% | 229,367 | - |
| 497 | RCEL | AVITA Medical, Inc. | 401.74M | -1.96% | 408,674 | 75.63M |
| 498 | CARL | Carlsmed, Inc. | 399.71M | -4.31% | 115,659 | 63.30M |
| 499 | SI | Shoulder Innovations, Inc. | 398.47M | -2.35% | 126,977 | 60.06M |
| 500 | PRLD | Prelude Therapeutics Incorporated | 392.41M | 1.06% | 339,245 | 22.42M |